Haermonics

Haermonics is a health care and medical devices startup based in The Netherlands, founded in 2015. The company's slogan "Haermonics for safer open heart surgery" reflects its mission to save lives, aiming to save 10,000 lives by 2030. Haermonics focuses on delivering an economical alternative for postoperative drainage products in the cardiac surgery market. The innovative technology offered by Haermonics provides a cost-effective high-end product, a drainage and flushing system, which not only offers economic value but also delivers smart clinical decision support by controlling and analyzing surgical blood loss.

The last investment in Haermonics was a Pre Seed Round investment on 01 September 2015. The investment came from NLC, providing essential support for the company's development and growth. Haermonics' technology is designed to offer an integrated solution for surgical blood loss and wound healing. It aims to provide targeted versatile therapy and smart integration within its complex working environment, ultimately improving patient outcomes after surgical procedures compared to current standards. With its focus on both economic and clinical benefits, Haermonics presents an interesting investment opportunity in the evolving medical devices and health care market.